Clinical Trial Update: Addition of Naltrexone to Methadone Taper [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the addition of naltrexone to a methadone taper for heroin dependence and related opioid/substance use disorders has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heroin Dependence
• Opioid Use Disorder
• Substance-related Disorders

Drugs mentioned

• Methadone (methadone)
• Naltrexone (Naltrexone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Heroin Dependence, Opioid-Related Disorders | Phase 2 | Status: COMPLETED